Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact

In-Press Preview

Articles in this category appear as authors submitted them for publication, prior to copyediting and publication layout.
Integrative 3D imaging and deep learning approach reveals cardiac fibroblast dynamics after myocardial infarction
Cardiac fibroblasts (CFs) are key mediators of heart failure progression, driving fibrotic scar formation after myocardial infarction (MI). Conventional preclinical assessment of MI relies on...
View: Text | PDF
Resource and Technical Advance In-Press Preview Cardiology Cell biology

Integrative 3D imaging and deep learning approach reveals cardiac fibroblast dynamics after myocardial infarction

  • Text
  • PDF
Abstract

Cardiac fibroblasts (CFs) are key mediators of heart failure progression, driving fibrotic scar formation after myocardial infarction (MI). Conventional preclinical assessment of MI relies on two-dimensional histology, which cannot resolve the three-dimensional (3D) architecture of the injured heart. Understanding the molecular mechanisms of CF activation is critical for identifying new drug targets, yet spatial mapping of gene expression in intact hearts remains challenging. To address this, we developed a high-throughput imaging pipeline that combined single-cell–resolution gene expression profiling in cleared whole hearts with light-sheet fluorescence microscopy and an AI-driven analysis framework optimized for MI characterization. Using this approach, we mapped expression of periostin (Postn), collagen triple-helix repeat containing 1 (Cthrc1), and asporin (Aspn) — genes associated with CF activation. These markers were detected by day 3 post-infarction in the endocardium and border zone, preceding collagenous scar formation, then expanded across the infarcted myocardium before declining toward baseline during scar maturation. These findings revealed a spatially organized progression of fibrosis-associated gene expression that began in defined regions of the injured heart and subsequently extended throughout the infarcted myocardium. Whole-organ gene-expression imaging combined with deep-learning-based analysis enabled quantitative spatiotemporal mapping of molecular remodeling and provides a framework for investigating disease progression in intact organs.

Authors

Sheyla Barrado-Ballestero, María López-Moreno, Jorge Cobos-Figueroa, Max Hahn, Cristina Pogontke-Díaz, Tor Biering-Sørensen, Casper G. Salinas, Juan Antonio Guadix, José M. Perez-Pomares, Adrián Ruiz-Villalba, Urmas Roostalu

×

Circadian disruption worsens postseptic pulmonary fibrotic remodeling through a CLOCK/PIEZO1-linked myeloid immunometabolic program
Background: Whether circadian rhythm disruption (CRD) promotes fibrotic remodeling after septic lung injury remains unclear. We tested whether CRD drives this process through macrophage...
View: Text | PDF
Research In-Press Preview Cell biology Pulmonology

Circadian disruption worsens postseptic pulmonary fibrotic remodeling through a CLOCK/PIEZO1-linked myeloid immunometabolic program

  • Text
  • PDF
Abstract

Background: Whether circadian rhythm disruption (CRD) promotes fibrotic remodeling after septic lung injury remains unclear. We tested whether CRD drives this process through macrophage CLOCK–PIEZO1 signaling. Methods: Lung specimens from patients with sepsis-associated lung injury and non-injured controls were analyzed alongside public murine lung transcriptomic datasets. Mice underwent cecal ligation and puncture or sham surgery and were maintained under stable or repeatedly shifted light–dark cycles; selected experiments included LysM-lineage Piezo1 deletion. Day-3 lung injury and day-28 fibrosis were assessed, and mechanisms were defined using genetic, biochemical and co-culture approaches. Results: CRD suppressed CLOCK expression in macrophage-lineage cells, leading to increased PIEZO1 expression and aggravated collagen deposition. CLOCK repressed Piezo1 transcription through a promoter E-box. Loss of myeloid Clock reduced Clock mesor and amplitude by 66.3% and 90.3%, respectively, increased Piezo1 mesor by 54.0%, and produced genotype-by-rhythm interactions for both genes (P < 0.0001). PIEZO1 activation impaired lysosomal acid lipase (LAL)–dependent lipophagy and promoted ZDHHC19-mediated peptidylarginine deiminase 4 (PAD4) palmitoylation and extracellular-trap formation. LysM-lineage Piezo1 deletion attenuated fibrosis. PIEZO1 inhibition or DNase I reduced epithelial injury and fibroblast activation induced by extracellular DNA-rich macrophage signals. Conclusions: CRD promotes post-septic fibrosis through a CLOCK–PIEZO1-linked macrophage immunometabolic program, identifying PIEZO1, extracellular DNA-rich traps and impaired lipid clearance as candidate targets.

Authors

Xiaohua Wang, Aming Sang, Wei Wang, Yujia Liu, Zirui Zhao, Haoxiang Li, Xiaoqi Xiong, Jie Cai, Ming Xu, Xinyi Li

×

Empagliflozin preserves cardiac function and modulates metabolism in a mouse model of Duchenne muscular dystrophy
Duchenne muscular dystrophy (DMD) is a fatal genetic disorder characterized by skeletal muscle degeneration and cardiomyopathy. Effective cardiac therapies remain limited. This study investigated...
View: Text | PDF
Research In-Press Preview Cardiology Cell biology Muscle biology

Empagliflozin preserves cardiac function and modulates metabolism in a mouse model of Duchenne muscular dystrophy

  • Text
  • PDF
Abstract

Duchenne muscular dystrophy (DMD) is a fatal genetic disorder characterized by skeletal muscle degeneration and cardiomyopathy. Effective cardiac therapies remain limited. This study investigated the therapeutic potential of the sodium-glucose cotransporter 2 (SGLT2) inhibitor empagliflozin (EMPA) in the dystrophin-deficient DBA2/J-mdx mouse model of DMD. Male mice received control chow or EMPA-containing chow (~25mg/kg/day), and cardiac function was evaluated longitudinally using four-dimensional ultrasound imaging. EMPA did not alter left ventricular mass or volume but delayed the onset of systolic dysfunction, preserving ejection fraction (EF) for 12 weeks and maintaining significantly higher EF through 24 weeks. EMPA also attenuated progressive impairments in systolic and diastolic myocardial deformation. Functional preservation was accompanied by reduced cardiomyocyte hypertrophy and reduced expression of cardiac stress genes. EMPA increased mtDNA copy number, reduced mtDNA damage, preserved the mtDNA-encoded respiratory chain protein MT-CO1, and increased myocardial ATP content, supporting improved mitochondrial integrity and myocardial energetic capacity. In addition, EMPA induced transcriptional changes consistent with enhanced fatty acid and ketone metabolism. Systemically, EMPA improved growth trajectory, preserved relative lean mass, increased skeletal muscle torque, attenuated fiber-type remodeling, and did not adversely affect renal function. Together, these findings support SGLT2 inhibitors as a promising therapeutic strategy for DMD-associated cardiomyopathy.

Authors

Benjamin J. Zeidler, Connor Thomas, John P. Salvas, Areli Jannes S. Javier, Alyssa M. Richards, Linda A. Bean, Conner C. Earl, Akanksha Agrawal, Niharika Narra, Steven N. Kozakiewicz, Lifan Zeng, Carol A Witczak, Joshua R Huot, Il-Man Kim, Meena S. Madhur, Mark C. Kowala, Larry W. Markham, Craig J. Goergen, Steven S. Welc

×

Type 1-polarized DC immunotherapeutic contains heterogeneous populations with IL-12p70 production restricted to a rare subset
Monocyte-derived DC therapies programmed for robust IL-12p70 production have been associated with favorable outcomes in cancer clinical trials. However, clinical responses remain inconsistent even...
View: Text | PDF
Research In-Press Preview AIDS/HIV Immunology Oncology

Type 1-polarized DC immunotherapeutic contains heterogeneous populations with IL-12p70 production restricted to a rare subset

  • Text
  • PDF
Abstract

Monocyte-derived DC therapies programmed for robust IL-12p70 production have been associated with favorable outcomes in cancer clinical trials. However, clinical responses remain inconsistent even under standardized protocols, and the cellular basis for this variability is unknown. We leveraged single-cell multiomics to characterize two widely used DC platforms, the high-IL-12p70-producing α-Type-1-polarized DC (αDC1) and the IL-12p70-deficient DC induced in the presence of PGE 2 (PGE2-DC), at baseline and following rhCD40L activation. DC generated from 7 healthy participants representing the spectrum of rhCD40L-induced IL-12p70 production were profiled by transcriptome analysis with 42-plex surface proteomics, multiplex ELISA, and ELISpot quantification of IL-12p70-producing cells. While αDC1 and PGE2-DC distinctly responded to rhCD40L, αDC1 alone comprised 3 transcriptionally and phenotypically distinct subpopulations in resting and stimulated states. Only a limited fraction of αDC1 coexpressed IL12A and IL12B (IL-12p70 producers), confirmed by ELISpot at the protein level. The distribution of αDC1 subclusters varied markedly between individuals and correlated with bulk cytokine and chemokine secretion profiles. Magnetic enrichment on the surface marker CD116 yielded αDC1 fractions that differentially primed naïve CD4 + T cells, demonstrating these subpopulations are functionally divergent and separable. This heterogeneity may underlie inconsistent clinical outcomes, providing a rationale for subcluster-based release criteria and patient stratification.

Authors

Allison E. DePuyt, Peter E. J. Shoucair, Holly A. Bilben, Jeremy Martinson, Bernard J.C. Macatangay, Charles Rinaldo, Pawel Kalinski, Robbie B. Mailliard

×

Epigenome-wide association study of kynurenine-to-tryptophan ratio in chronic kidney disease
View: Text | PDF
Research Letter In-Press Preview Clinical Research Nephrology

Epigenome-wide association study of kynurenine-to-tryptophan ratio in chronic kidney disease

  • Text
  • PDF
Abstract

Authors

Yuning Liu, Yang Li, Aditya Surapaneni, Matthew Muller, Carina M. Flaherty, Bing Yu, Eugene P. Rhee, Zulema Rodriguez-Hernandez, Pascal Schlosser, Jonathan D Newman, Kelly V. Ruggles, Jeffrey S. Berger, Morgan E. Grams

×

Placental transcriptomes differ in human pregnancies complicated by severe fetal left heart obstruction
The etiology of severe left-sided obstructive lesions (LSOL) of the heart, a common form of congenital heart disease (CHD), often remains unknown even after comprehensive genetic testing....
View: Text | PDF
Research In-Press Preview Development Reproductive biology

Placental transcriptomes differ in human pregnancies complicated by severe fetal left heart obstruction

  • Text
  • PDF
Abstract

The etiology of severe left-sided obstructive lesions (LSOL) of the heart, a common form of congenital heart disease (CHD), often remains unknown even after comprehensive genetic testing. Preclinical models implicate placental perturbations in abnormal cardiogenesis; however, little is known about connections between human placenta and fetal cardiac diseases. We profiled term placentas from severe LSOL pregnancies (n = 20) with and without placental pathologies and healthy controls (n = 10) to test whether severe fetal LSOL is associated with distinct transcriptomic and cellular states. Bulk RNA-sequencing of archival formalin-fixed paraffin-embedded tissues identified 1,030 differentially expressed protein-coding genes (580 [up], 450 [down]). Upregulated programs involved heart-valve development, endothelial signaling, and extracellular-matrix processes; while endocrine, trophoblast and gamma-aminobutyric acid signaling processes were downregulated. Severe LSOL pregnancies with histologically normal placentas showed enrichment of lymphatic-vascular development and cyclic-nucleotide signaling. Digital deconvolution analysis inferred reduced trophoblast fractions with reciprocal increase in endothelial and immune cell types. These findings support a unique placental gene expression in abnormal cardiac development, even in the absence of overt placental histopathology. These RNA expression signatures may serve as candidate biomarkers and lay the groundwork for mechanistic studies of the heart-placenta axis and future risk stratification in pregnancies with fetuses diagnosed with severe LSOL.

Authors

Rachel L. Leon, Huan Lu, Maria M. Ossa Galvis, Imran N. Mir, Bowen Xiong, Tao Wang, Durga Udayakumar

×

A universal platform for TCRα/β removal enables safer and more potent TCR therapies and autoimmune modeling
Adoptive T-cell therapies using tumour-specific T-cell receptors (TCRs) are limited by competition with endogenous receptors, impairing efficacy and posing risks of off-target autoreactivity. Here...
View: Text | PDF
Research In-Press Preview Immunology

A universal platform for TCRα/β removal enables safer and more potent TCR therapies and autoimmune modeling

  • Text
  • PDF
Abstract

Adoptive T-cell therapies using tumour-specific T-cell receptors (TCRs) are limited by competition with endogenous receptors, impairing efficacy and posing risks of off-target autoreactivity. Here we present a CRISPR-based platform that selectively eliminates both endogenous TCR-α and -β chains without affecting transgenic TCRs, irrespective of codon optimization. This approach achieves >90% deletion efficiency in Jurkat and primary human T cells, enhancing expression and functional potency of transgenic receptors. Using an HLA-A*02:01-restricted DMF5 TCR, we show that dual TCR ablation boosts antigen-specific activation and cytotoxicity in vitro and enhances tumor clearance in vivo in human immune system (HIS) mice and prevents graft-versus-host disease (GVHD). Targeted locus amplification showed that CRISPR-induced double-strand breaks did not alter lentiviral integration profiles, supporting genomic safety. Extending this approach to four insulin-reactive TCRs demonstrated that endogenous receptor removal increased transduction efficiency and functional activity, with one (1E6) showing selective activation and infiltration of islet grafts (SC-islets) in vivo. This study establishes a universal, safe, and scalable genome-editing platform for generating functionally precise human T cells. By integrating cancer immunotherapy and autoimmune disease modelling within a single framework, it provides a preclinical rationale for dual endogenous TCR removal to improve specificity, safety, and therapeutic efficacy in TCR-based cell therapies.

Authors

Giorgia Zanetti, Sameena Nikhat, Mateusz Legut, Austin Chen, Farshid Fathi, Nathan Suek, Nato Teteloshvili, Hao Wei Li, Xiaolan Ding, Daniel Traum, Klaus H. Kaestner, Ryan E. Hoang, Andrew K. Sewell, Audrey V. Parent, Remi J. Creusot, Megan Sykes, Mohsen Khosravi-Maharlooei

×

Molecular imaging of the TGF-β activating integrin αvβ6 detects chronic lung allograft dysfunction
TGF-β-activating integrins promote solid-organ fibrosis, suggesting their potential as disease markers. Chronic lung allograft dysfunction (CLAD), a progressive fibrotic complication that limits...
View: Text | PDF
Research In-Press Preview Immunology Pulmonology

Molecular imaging of the TGF-β activating integrin αvβ6 detects chronic lung allograft dysfunction

  • Text
  • PDF
Abstract

TGF-β-activating integrins promote solid-organ fibrosis, suggesting their potential as disease markers. Chronic lung allograft dysfunction (CLAD), a progressive fibrotic complication that limits lung transplant survival, is driven by intragraft TGF-β activation. However, TGF-β-activating integrin expression patterns remain undefined in lung transplants. Single-cell RNA sequencing and proteomic analysis of tissue specimens from a mouse CLAD model and human explanted lungs with CLAD revealed high levels of the TGF-β-activating integrin αvβ6, primarily localized to fibrosis-associated Keratin 8+ alveolar transitional epithelial cells, which were greatly reduced in tolerant lungs. Molecular imaging with a newly optimized positron emission tomography radiotracer specific for αvβ6, [64Cu]Cu-DOTA-A20-K16R, showed significantly higher uptake in CLAD than in tolerant transplants. [64Cu]Cu-DOTA-A20-K16R activity was also reduced by experimental treatments that lowered αvβ6 expression and inhibited CLAD severity. Finally, [64Cu]Cu-DOTA-A20-K16R autoradiographic analysis of human explanted lungs with CLAD showed elevated activity that correlated with increased αvβ6 expression. Collectively, these findings illustrate the potential utility of αvβ6 molecular imaging for detecting CLAD pathogenesis.

Authors

Marlene Cano, Chandra S. Bathula, Fuyi Liao, Cristian Wieczorek Villas Boas, Yan Tao, Zhiyi Liu, Ricky Ebenezer, Victoria Davis, Allison Cannady, Dequan Zhou, Shunning Liang, Hanqiu Zhao, Derek E. Byers, Alexander S. Krupnick, Daniel Kreisel, Susan M. Lin, Allen Duong, Tereza Martinu, Zhiyu Dai, Buck E. Rogers, Andrew E. Gelman

×

Dsg2 truncation causes a severe intestinal epithelial barrier breakdown and alters microbiome and immune response
Inflammatory bowel diseases (IBD) including Crohn’s disease (CD) are characterized by impaired intestinal epithelial barrier (IEB) function. Alterations in the desmosomal cadherin desmoglein 2...
View: Text | PDF
Research In-Press Preview Cell biology Inflammation

Dsg2 truncation causes a severe intestinal epithelial barrier breakdown and alters microbiome and immune response

  • Text
  • PDF
Abstract

Inflammatory bowel diseases (IBD) including Crohn’s disease (CD) are characterized by impaired intestinal epithelial barrier (IEB) function. Alterations in the desmosomal cadherin desmoglein 2 (Dsg2) have been linked to loss of IEB and intestinal inflammation in IBD. We investigated the pathogenic impact of a cytoplasmatic-truncating mutation in the desmosomal cadherin desmoglein 2 gene (DSG2) in an IBD patient. Genetic analysis of a CD patient revealed a likely pathogenic DSG2 mutation leading to a truncated protein lacking part of the intracellular domain. Generation of an enterocyte-specific mouse model to recapitulate the human mutation resulted in a lethal intestinal barrier defect which was evident in homozygous but not in heterozygous mice. In vitro, barrier defects correlated with changes in Dsg2 mobility and upregulation of pore-forming tight junction protein claudin-2. Organoids derived from heterozygous Dsg2 truncated mice exhibited increased epithelial susceptibility to proinflammatory cytokines. Bulk RNAseq followed by gene ontology analysis in homozygous mice revealed a skewed IL17/IL23 response overlapping with transcriptional changes in patients with CD. Furthermore, 16S rRNA sequencing revealed alterations in microbiome composition in animals that carried the Dsg2 truncation. In summary, a patient-derived mutation in the DSG2 gene causing cytoplasmic truncation in homozygous state induced a lethal intestinal barrier breakdown in mice paralleled by altered gut microbiota and intestinal immune response.

Authors

Daniela Kugelmann, Alexander García-Ponce, Nadja Thielemann, Mariya Y. Radeva, Maresa Anders, Da Eun Kang, Christian Siadjeu, Natalie Burkard, Anja K.E. Horn, Jessica Neubauer, Matthias Hiermaier, Desalegn T. Egu, Christoph Schmitz, Oliver Kurzai, Katri S. Vuopala, Outi Kuismin, Nicolas Schlegel, Jens Waschke

×

Effects of calreticulin mutations on HLA class I expression in myeloproliferative neoplasms
Essential thrombocythemia (ET) and myelofibrosis (MF) are myeloproliferative neoplasms (MPN) that can result from heterozygous or homozygous mutations in the calreticulin (CRT) gene (CALR). Mutant...
View: Text | PDF
Research In-Press Preview Immunology Oncology

Effects of calreticulin mutations on HLA class I expression in myeloproliferative neoplasms

  • Text
  • PDF
Abstract

Essential thrombocythemia (ET) and myelofibrosis (MF) are myeloproliferative neoplasms (MPN) that can result from heterozygous or homozygous mutations in the calreticulin (CRT) gene (CALR). Mutant CRT binds to the thrombopoietin receptor to induce signaling that drives ET and MF. CRT is also a chaperone for the assembly of the highly polymorphic human leukocyte antigen (HLA) class I molecules. The effects of heterozygous versus homozygous MPN CALR mutations on the expression of HLA class I variants are unknown. To assess mutant CRT-induced changes to HLA class I expression, we generated CRISPR-based mutant CALR knock-in cell lines and CALR-knockout cell lines reconstituted with wild-type or MPN mutant CALR and also undertook measurements in MPN patient platelets and monocytes. Collectively, our findings indicate that heterozygous CALR mutations preserve HLA class I surface expression, whereas full loss of wild-type CRT results in marked, allele-dependent reductions in HLA class I expression, which are rescued by wild-type CRT but not MPN mutants. Reduced expression of CRT-dependent HLA class I in cells lacking a functional CRT induces natural killer (NK) cell activation. These studies identify specific HLA class I alleles and homozygous CALR mutations as prerequisites for low HLA class I expression in MPN.

Authors

Amanpreet Kaur, Grace Pagnucco, Fawziyah S. Khatri, Harini Desikan, Malathi Kandarpa, Matthew Cusick, Moshe Talpaz, Malini Raghavan

×

TSC2-Mutant Yucatan Minipig Cardiac Rhabdomyoma Model Reveals mTORC1 Activation and MITF/TFE Expression Signature
Tuberous sclerosis complex (TSC) is an inherited tumor predisposition syndrome caused by pathogenic variants in TSC1 or TSC2, yet no animal model faithfully recapitulates the cardiac rhabdomyomas...
View: Text | PDF
Resource and Technical Advance In-Press Preview Genetics Oncology

TSC2-Mutant Yucatan Minipig Cardiac Rhabdomyoma Model Reveals mTORC1 Activation and MITF/TFE Expression Signature

  • Text
  • PDF
Abstract

Tuberous sclerosis complex (TSC) is an inherited tumor predisposition syndrome caused by pathogenic variants in TSC1 or TSC2, yet no animal model faithfully recapitulates the cardiac rhabdomyomas (CR) that are among its earliest manifestations. We generated a heterozygous TSC2-mutant Yucatan minipig carrying the recurrent pathogenic TSC2 p.Arg505* variant and characterized its cardiac phenotype using histopathology, immunohistochemistry, and RNA sequencing. TSC2-mutant minipigs consistently developed multiple CR that closely resembled human lesions, including enlarged glycogen-rich spider cells and activation of mechanistic target of rapamycin complex 1 (mTORC1) signaling. Comparative transcriptomic analyses demonstrated enrichment of a conserved TSC-associated gene expression program and activation of microphthalmia/transcription factor E (MITF/TFE)-regulated lysosomal pathways in both human and minipig tumors. Although other manifestations of TSC were not observed during the first year of life, this large-animal model faithfully reproduced the principal histopathologic and molecular features of human CR. These findings have established the TSC2-mutant Yucatan minipig as what we believe to be the first large-animal model of TSC-associated CR and provide a physiologically relevant platform for investigating tumor pathogenesis, mechanisms of spontaneous regression, and therapeutic strategies targeting mTORC1- and MITF/TFE-dependent signaling.

Authors

Elias Bou Farhat, Heng Du, Chrystalle Katte Carreon, Jad Halawi, Sophie Kudler, Magdalena Losko, Zachary T. Herbert, Adrienne L. Watson, Daniel Carlson, Dennis A. Webster, Derek M. Korpela, David M. Meredith, Elizabeth P. Henske, David J. Kwiatkowski

×

Synovial immune endotypes associate with structural severity across canine and human osteoarthritis
Osteoarthritis (OA) is a heterogeneous disease in which synovial inflammation drives structural progression and pain, yet the molecular diversity of synovitis remains poorly defined. Here, we...
View: Text | PDF
Research In-Press Preview Clinical Research Inflammation

Synovial immune endotypes associate with structural severity across canine and human osteoarthritis

  • Text
  • PDF
Abstract

Osteoarthritis (OA) is a heterogeneous disease in which synovial inflammation drives structural progression and pain, yet the molecular diversity of synovitis remains poorly defined. Here, we performed a multimodal characterization of synovial tissues from 48 dogs with naturally occurring OA, integrating histopathology, immunohistochemistry, transcriptomics, MRI, and soluble mediator profiling. This analysis identified three discrete synovial pathotypes, pauci-immune, diffuse myeloid, and lympho-myeloid, defined by distinct immune cell composition and transcriptional programs reflecting biologically distinct endotypes. The lympho-myeloid pathotype, characterized by ectopic lymphoid structures and adaptive immune enrichment, was independently associated with greater structural joint damage on MRI despite comparable clinical scores, demonstrating that tissue stratification captures heterogeneity invisible to clinical assessment alone. Composite soluble mediator signatures correlated with disease severity across pathotypes. Cross-species analyses integrating a large human synovial cohort revealed conserved pathotype architecture and shared gene networks, including tyrosine kinase signaling and B cell receptor activation, validating the translational relevance of the canine model. Together, these findings provide a framework for patient stratification and therapeutic target discovery in OA, with broad implications for precision medicine within a One Medicine perspective.

Authors

Anaëlle Drieu-Vincent, Julien De Lima, Floriane M. Etienne, Romain Guiho, Noémie Podevin, Richard Danger, Florence Lezin, Nicolas Gaigeard, Sophie Allain, Jérôme Abadie, Thomas Rousseau, Pierre Maitre, Olivier Gauthier, Jérôme Guicheux, Marion S. Fusellier, Marie-Astrid Boutet

×

Alveolar Type II Cell-derived MMP1high basal cells promote destructive microcysts in idiopathic pulmonary fibrosis
Alveolar microcysts, a hallmark of Idiopathic Pulmonary Fibrosis (IPF), are basal cell (BC)-lined structures that develop near terminal airways and correlate with poor clinical outcomes. Using...
View: Text | PDF
Research In-Press Preview Cell biology Pulmonology

Alveolar Type II Cell-derived MMP1high basal cells promote destructive microcysts in idiopathic pulmonary fibrosis

  • Text
  • PDF
Abstract

Alveolar microcysts, a hallmark of Idiopathic Pulmonary Fibrosis (IPF), are basal cell (BC)-lined structures that develop near terminal airways and correlate with poor clinical outcomes. Using primary-cell organoids and spatial transcriptomics, we identified striking epithelial similarities between respiratory bronchioles (RBs) and IPF alveolar microcysts, both containing AT0 (ABCA3+/SCGB3A2+), SCGB3A2+, and basaloid/BC populations, although basaloid/BCs were markedly expanded in IPF microcysts. A CEACAM6+ subset of normal RB epithelial cells, termed respiratory airway secretory cells (RASCs), consisted predominantly of SCGB3A2+ cells with only rare BCs (1–5%) that by RNA trajectory analysis suggested BCs arise from SCGB3A2+ progenitors. Accordingly, in organoid cultures nearly all RASC-derived colonies converted to BCs within 9 days, resembling colonies generated by purified BCs. BCs derived from either RASCs or normal alveolar type II (AT2) cells strongly expressed the collagenase matrix metalloproteinase-1 (MMP1), recapitulating the phenotype of BCs lining IPF microcysts. MMP1high BCs degraded type I collagen ex vivo and generated microcyst-like structures in vivo following xenotransplantation, both abolished by MMP activity inhibition or specific MMP1 deletion by sh-RNAi. Finally, a Frizzled-5 WNT agonist antibody reversed the MMP1high phenotype, identifying AT2- and RB-derived basal cell transdifferentiation as a previously unrecognized driver of alveolar destruction and microcyst formation in IPF and a potential therapeutic target.

Authors

Marylene Toigo, Kiana Garakani, Alexis N. Brumwell, Ying Wei, Tsung Che Ho, Paul J. Wolters, Michael A. Matthay, Stefano A. Iantorno, Vincent C. Auyeung, Harold A. Chapman, Claude Jourdan Le Saux

×

Duodenal macrophages depletion and dysfunction contribute to gut barrier dysfunction in alcohol use disorder
In alcohol use disorder (AUD), duodenal macrophage number are reduced, but the underlying mechanisms and consequences for gut permeability remain unknown. Actively drinking AUD patients undergoing...
View: Text | PDF
Research In-Press Preview Clinical Research Gastroenterology Immunology

Duodenal macrophages depletion and dysfunction contribute to gut barrier dysfunction in alcohol use disorder

  • Text
  • PDF
Abstract

In alcohol use disorder (AUD), duodenal macrophage number are reduced, but the underlying mechanisms and consequences for gut permeability remain unknown. Actively drinking AUD patients undergoing standardized inpatient detoxification and healthy controls were enrolled. Fasting blood samples and duodenal biopsies were analyzed using proteomics, histology, multiplex immunohistofluorescence, flow cytometry, and quantitative polymerase chain reaction. Circulating monocytes were differentiated ex vivo into macrophages to assess migration, differentiation, phagocytosis, and cytokine release following stimulation with bacterial products. Gut permeability was evaluated using urinary 51Chromium- ethylenediaminetetraacetic acid excretion, and plasma surrogate markers of microbial translocation. AUD patients showed markedly reduced duodenal macrophages despite increased circulating monocytes and tissue monocyte-attracting chemokines. AUD monocytes exhibited reduced CCR2 expression and downregulation of tissue proteins involved in adhesion and trans-endothelial migration, thereby decreasing mucosal infiltration. Early macrophage differentiation associated was impaired, with reduced CSF1, CSF2, IL-34, and CSF1 receptor expression. Despite preserved phagocytic capacity, residual tissue macrophages displayed a mixed immune phenotype with reduced expression of scavenger receptors involved in microbial responses and cytokine hyporesponsiveness to lipopolysaccharide and peptidoglycan. Reduced macrophage numbers correlated with increased intestinal permeability and markers of microbial translocation. These results link disruption of the duodenal monocyte-macrophage axis to intestinal barrier failure in AUD.

Authors

Yifan Hu, Jerome Ambroise, Luca Maccioni, Laure-Alix Clerbaux, Caroline Bouzin, Bernd Schnabl, Peter Stärkel

×

Gut microbiota are required for reduced IGF-1 and bone growth in postnatal cystic fibrosis mice
Children with cystic fibrosis (CwCF) have impaired linear growth that correlates with poor clinical outcomes. Growth-stunted CwCF also exhibit a marked fecal dysbiosis, and lower serum levels of...
View: Text | PDF
Research In-Press Preview Bone biology Microbiology

Gut microbiota are required for reduced IGF-1 and bone growth in postnatal cystic fibrosis mice

  • Text
  • PDF
Abstract

Children with cystic fibrosis (CwCF) have impaired linear growth that correlates with poor clinical outcomes. Growth-stunted CwCF also exhibit a marked fecal dysbiosis, and lower serum levels of the gut microbiome-regulated growth factor IGF-1, relative to those without stunting. We hypothesized that the CF gut microbiome negatively impacts IGF-1 and skeletal growth in CwCF. To test this hypothesis, we compared bone phenotypes, IGF-1 and linear growth trajectories of C57BL/6 Cftrtm1Unc mutant mice (CF) to their wild-type littermates (WT) either colonized with (specific pathogen free, SPF) or without (germ-free, GF) normal microbiota. At 4 weeks of age, CF mice had reduced femur length and diminished serum IGF-1 compared to WT mice under SPF, but not GF, conditions. In contrast, by 14 weeks femur lengths and IGF-1 were similar in CF mice raised under both SPF and GF conditions. Accordingly, we observed significantly slower growth in CF mice under SPF, but not GF, conditions only from 1 to 4 weeks. CF mice also exhibited more pronounced relative taxonomic and functional dysbiosis at 4 compared with 14 weeks. These results suggest that gut microbiota play a critical role in early postnatal CF skeletal growth impairment, while microbe-independent mechanisms likely predominate in later life.

Authors

Xiaomeng You, Jisun Paik, Stacey Meeker, Kevin S. Mears, Christopher E. Pope, Hillary S. Hayden, Kelsi Penewit, Adam Waalkes, Sruthi Sridevan, Stephen J. Salipante, Lucas R. Hoffman, Julia F. Charles

×

CDH3-directed immunotherapy targets basal-like hormone receptor negative prostate cancer and breast cancer
Basal-like double-negative prostate cancer (DNPC) and triple-negative breast cancer (TNBC) are aggressive tumors with few targeted treatment options, raising the question of whether a shared,...
View: Text | PDF
Research In-Press Preview Immunology Oncology

CDH3-directed immunotherapy targets basal-like hormone receptor negative prostate cancer and breast cancer

  • Text
  • PDF
Abstract

Basal-like double-negative prostate cancer (DNPC) and triple-negative breast cancer (TNBC) are aggressive tumors with few targeted treatment options, raising the question of whether a shared, druggable cell-surface antigen can be leveraged for effective immunotherapy. Here, we integrated analyses of independent bulk and single-cell transcriptomic datasets with mechanistic and preclinical therapeutic studies to evaluate CDH3 (P-cadherin) as a candidate target in basal-like disease. CDH3 expression was consistently enriched in basal-like subtypes across prostate and breast cancer cohorts and was preferentially expressed in basal epithelial tumor compartments. Mechanistically, CDH3 expression was governed by a YAP1–WNT5A/ROR2 signaling axis, linking basal subtype gene expression to non-canonical Wnt signaling. To exploit this target, we evaluated both a CDH3-directed antibody-drug conjugate (ADC) and CDH3-specific chimeric antigen receptor (CAR)-T cells. The ADC exhibited antigen-dependent internalization and cytotoxicity in vitro and reduced metastatic tumor burden in vivo. CDH3 CAR-T cells showed antigen-specific activation and tumor cell killing in vitro and improved tumor control and survival in metastatic prostate and breast cancer xenograft models, with additional benefit when combined with PD-1 blockade (nivolumab). Together, these findings establish CDH3 as a clinically relevant and therapeutically actionable target and support CDH3-directed ADC and CAR-T strategies for aggressive, basal-like DNPC and TNBC.

Authors

Guoqiang Liu, Shiyu Wang, Ziyu Zeng, Loan Duong, Jing Yang, Nipuni Barupala, Yun Zhao, Sharif Rahmy, Shan Feng, Xiaotian Chi, Ariana Arce, Linchuan Jia, Jun Wan, Liang Cheng, Xuemin Lu, Xin Lu

×

ROCK2 inhibitor belumosudil overcomes resistance to KRAS inhibition in pancreatic cancer models
View: Text | PDF
Research Letter In-Press Preview Cell biology Oncology

ROCK2 inhibitor belumosudil overcomes resistance to KRAS inhibition in pancreatic cancer models

  • Text
  • PDF
Abstract

Authors

Alejandra M. Marinelarena, Thao D. Pham, Jeffrey H. Becker, Apurba Majumder, Hidayatullah G. Munshi

×

Natural killer cells from children with obesity exhibit a persistent ‘trained’ response to influenza
Children and adults living with obesity have more severe influenza A virus (IAV) infection, but the underlying mechanisms are unclear. Natural killer (NK) cells play a key role in the innate immune...
View: Text | PDF
Research In-Press Preview Immunology Infectious disease

Natural killer cells from children with obesity exhibit a persistent ‘trained’ response to influenza

  • Text
  • PDF
Abstract

Children and adults living with obesity have more severe influenza A virus (IAV) infection, but the underlying mechanisms are unclear. Natural killer (NK) cells play a key role in the innate immune responses to IAV and clearance of IAV-infected cells. ‘Trained immunity’ of NK cells (and other innate immune cells) refers to an initial stimulus (i.e. obesity) inducing metabolic and epigenetic changes that make these cells hyperinflammatory upon restimulation (i.e. with IAV). Here, we tested whether obesity in children induces trained immunity in NK cells. We have show that NK cells from children with obesity have a hyperinflammatory ‘trained’ phenotype, with increased expression of activation markers TLR2, CCR2, TLR4, HLA-DR and CD11b compared to children without obesity. Furthermore, we have demonstrate that NK cells from children with obesity have a heightened ex vivo IFN-γ response to stimulation with IAV (A/Auckland/4/2009, H1N1 and HKx31, H3N2) and epigenetic changes consistent trained immunity. A decrease in BMI z-score following weight-management was not associated with a reduction in the IFN-γ response, suggesting that weight loss is not sufficient to normalise NK cell function. Better understanding of obesity-related immune modulation is critical for development of new therapeutic strategies and improving outcomes in future IAV pandemics

Authors

Ellesandra C. Noye, Megan Airey, Danielle K. Longmore, Hui Xu, David Chisanga, Christoph Saner, Meagan Carney, Meg Kaegi, Hiu On Man, M. Zeeshan Chaudhry, Liam C. Kealy, Julian D. J. Sng, Isabelle Hocking, Melanie Wu, Georgina McCallum, Gabrielle T. Belz, Kim L. Good-Jacobson, David Burgner, Siroon Bekkering, Kirsty Short

×

Intrinsic epithelial defects and NF-κB-dependent signaling heighten viral injury in biliary atresia
Targeted injury to the biliary epithelium and impaired bile flow are central mechanisms underlying childhood cholangiopathies. In biliary atresia (BA), immune-mediated cholangiocyte injury drives...
View: Text | PDF
Research In-Press Preview Hepatology Immunology Inflammation

Intrinsic epithelial defects and NF-κB-dependent signaling heighten viral injury in biliary atresia

  • Text
  • PDF
Abstract

Targeted injury to the biliary epithelium and impaired bile flow are central mechanisms underlying childhood cholangiopathies. In biliary atresia (BA), immune-mediated cholangiocyte injury drives progressive bile duct obstruction, yet epithelial-intrinsic programs regulating injury susceptibility remain incompletely defined. Here, we modeled virus-epithelium interactions using rhesus rotavirus (RRV) infection of human liver-derived cholangiocyte organoids from normal donors (NCO) and infants with BA at diagnosis (BACO-Dx) or transplantation (BACO-Tx). Compared with NCO, BA organoids displayed baseline defects in tight junction architecture and barrier function, with prominent epithelial disruption and apoptosis following RRV exposure. Transcriptomic profiling revealed that while NCO and BACO-Dx mounted predominantly interferon-associated antiviral responses, BACO-Tx exhibited an expanded inflammatory program characterized by enrichment of NF-κB (RELA/NFKB1) regulatory network at baseline and amplified by infection. Inhibition of NF-κB signaling with the hydrogen sulfide donor GYY4137 restored organoid growth, improved tight junction organization, reduced permeability, and attenuated RRV-induced apoptosis. In the murine BA model, GYY4137 improved disease severity, preserved bile duct architecture, and protected epithelial junctional integrity while limiting cholangiocyte apoptosis. These findings identify an epithelial NF-κB-predominant program as a key determinant of intrinsic susceptibility to viral injury in BA and support targeting cholangiocyte NF-κB signaling to suppress disease progression.

Authors

Wenqi Li, Ashley Fonseca-Mejia, Reena Mourya, Pavithra Sudhakara, Pranavkumar Shivakumar, Jorge A. Bezerra

×

A review of published personalized phage therapy cases in clinical practice
The increase in antimicrobial resistant infections has fueled a resurgent interest in bacteriophage (phage) therapy. We conducted a literature review of personalized phage therapy cases in the...
View: Text | PDF
Clinical Research and Public Health In-Press Preview Infectious disease Virology

A review of published personalized phage therapy cases in clinical practice

  • Text
  • PDF
Abstract

The increase in antimicrobial resistant infections has fueled a resurgent interest in bacteriophage (phage) therapy. We conducted a literature review of personalized phage therapy cases in the peer-reviewed, English-language literature reported between 1/1/2005, to 8/31/2025 for which individual patient data were available, identifying and synthesizing data from a total of 323 patients described in 83 studies. Most patients (68%, 221/323) were treated with ≥ 2 phages (a phage cocktail). The median concentration of phages was 108 PFU/mL (IQR 107–109). Most patients (76%, 246/323) received antibiotics concurrent with phage therapy. The median duration of therapy was 10 days (IQR 5–21). The most common indications for phage therapy were skin/soft tissue, pulmonary, orthopedic, osteoarticular, and genitourinary infections. 144 patients received fixed (off-the-shelf) phage preparations whereas 179 received bespoke phage preparations (i.e., personalized therapy). For cases where outcomes data were available, 78% (253/323), experienced clinical improvement while the targeted pathogen was eradicated in 61% (177/290) of cases. Nine patients had treatment withdrawn due to tolerability concerns. These data indicate that there is substantial heterogeneity in current personalized phage therapy clinical practices but that this approach can be successful.

Authors

Patrick M. Blankenberg, Robert Targ, Grace D. Cullen, Gina A. Suh, Krystyna Dąbrowska, Aarav Singh, Tiffany Luong, Daisuke Furukawa, Paul L. Bollyky

×

← Previous 1 2 3 … 141 142 Next →


Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts